Industry Research Reports

Home > Reports > Chemical & Material > Global Pharmaceutical Coating Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Pharmaceutical Coating Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-08-05

Pages: 136 Pages

Report ld: 4871938

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Pharmaceutical Coating market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Drug coating is the process of applying sugar or other film-forming materials to the outer surface of solid drug preparations (such as tablets, pills, etc.) in specific equipment according to a specific process, so that after drying, it becomes one or more multifunctional protective layers of different thicknesses and elasticities that are tightly adhered to the surface.

From a downstream perspective, Medicines accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Pharmaceutical Coating leading manufacturers including BASF, Evonik, Kerry, UPM Pharmaceuticals, Colorcon, Pharma Excipients, Ideal Cures, EasyCoat, Neha Life Sciences Pvt. Ltd., Spraycel Coatings, etc., dominate supply; the top five capture approximately % of global revenue, with BASF leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Coating market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

BASF
Evonik
Kerry
UPM Pharmaceuticals
Colorcon
Pharma Excipients
Ideal Cures
EasyCoat
Neha Life Sciences Pvt. Ltd.
Spraycel Coatings

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Tablets
Pills
Others

Segment by Application

Medicines
Health Products
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Pharmaceutical Coating study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Pharmaceutical Coating: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Pharmaceutical Coating Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Tablets

1.2.3 Pills

1.2.4 Others

1.3 Market Segmentation by Application

1.3.1 Global Pharmaceutical Coating Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Medicines

1.3.3 Health Products

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pharmaceutical Coating Revenue Estimates and Forecasts 2020-2031

2.2 Global Pharmaceutical Coating Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Pharmaceutical Coating Sales Estimates and Forecasts 2020-2031

2.4 Global Pharmaceutical Coating Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Pharmaceutical Coating Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Pharmaceutical Coating Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Pharmaceutical Coating Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Tablets Market Size by Manufacturers

4.5.2 Pills Market Size by Manufacturers

4.5.3 Others Market Size by Manufacturers

4.6 Global Pharmaceutical Coating Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Pharmaceutical Coating Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Pharmaceutical Coating Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Pharmaceutical Coating Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Pharmaceutical Coating Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Pharmaceutical Coating Sales and Revenue by Type (2020-2031)

7.4 North America Pharmaceutical Coating Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Pharmaceutical Coating Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Pharmaceutical Coating Sales and Revenue by Type (2020-2031)

8.4 Europe Pharmaceutical Coating Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Pharmaceutical Coating Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Pharmaceutical Coating Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Pharmaceutical Coating Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Pharmaceutical Coating Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Pharmaceutical Coating Sales and Revenue by Type (2020-2031)

10.4 Central and South America Pharmaceutical Coating Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Pharmaceutical Coating Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Pharmaceutical Coating Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Pharmaceutical Coating Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Pharmaceutical Coating Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 BASF

12.1.1 BASF Corporation Information

12.1.2 BASF Business Overview

12.1.3 BASF Pharmaceutical Coating Product Models, Descriptions and Specifications

12.1.4 BASF Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 BASF Pharmaceutical Coating Sales by Product in 2024

12.1.6 BASF Pharmaceutical Coating Sales by Application in 2024

12.1.7 BASF Pharmaceutical Coating Sales by Geographic Area in 2024

12.1.8 BASF Pharmaceutical Coating SWOT Analysis

12.1.9 BASF Recent Developments

12.2 Evonik

12.2.1 Evonik Corporation Information

12.2.2 Evonik Business Overview

12.2.3 Evonik Pharmaceutical Coating Product Models, Descriptions and Specifications

12.2.4 Evonik Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Evonik Pharmaceutical Coating Sales by Product in 2024

12.2.6 Evonik Pharmaceutical Coating Sales by Application in 2024

12.2.7 Evonik Pharmaceutical Coating Sales by Geographic Area in 2024

12.2.8 Evonik Pharmaceutical Coating SWOT Analysis

12.2.9 Evonik Recent Developments

12.3 Kerry

12.3.1 Kerry Corporation Information

12.3.2 Kerry Business Overview

12.3.3 Kerry Pharmaceutical Coating Product Models, Descriptions and Specifications

12.3.4 Kerry Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Kerry Pharmaceutical Coating Sales by Product in 2024

12.3.6 Kerry Pharmaceutical Coating Sales by Application in 2024

12.3.7 Kerry Pharmaceutical Coating Sales by Geographic Area in 2024

12.3.8 Kerry Pharmaceutical Coating SWOT Analysis

12.3.9 Kerry Recent Developments

12.4 UPM Pharmaceuticals

12.4.1 UPM Pharmaceuticals Corporation Information

12.4.2 UPM Pharmaceuticals Business Overview

12.4.3 UPM Pharmaceuticals Pharmaceutical Coating Product Models, Descriptions and Specifications

12.4.4 UPM Pharmaceuticals Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 UPM Pharmaceuticals Pharmaceutical Coating Sales by Product in 2024

12.4.6 UPM Pharmaceuticals Pharmaceutical Coating Sales by Application in 2024

12.4.7 UPM Pharmaceuticals Pharmaceutical Coating Sales by Geographic Area in 2024

12.4.8 UPM Pharmaceuticals Pharmaceutical Coating SWOT Analysis

12.4.9 UPM Pharmaceuticals Recent Developments

12.5 Colorcon

12.5.1 Colorcon Corporation Information

12.5.2 Colorcon Business Overview

12.5.3 Colorcon Pharmaceutical Coating Product Models, Descriptions and Specifications

12.5.4 Colorcon Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Colorcon Pharmaceutical Coating Sales by Product in 2024

12.5.6 Colorcon Pharmaceutical Coating Sales by Application in 2024

12.5.7 Colorcon Pharmaceutical Coating Sales by Geographic Area in 2024

12.5.8 Colorcon Pharmaceutical Coating SWOT Analysis

12.5.9 Colorcon Recent Developments

12.6 Pharma Excipients

12.6.1 Pharma Excipients Corporation Information

12.6.2 Pharma Excipients Business Overview

12.6.3 Pharma Excipients Pharmaceutical Coating Product Models, Descriptions and Specifications

12.6.4 Pharma Excipients Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Pharma Excipients Recent Developments

12.7 Ideal Cures

12.7.1 Ideal Cures Corporation Information

12.7.2 Ideal Cures Business Overview

12.7.3 Ideal Cures Pharmaceutical Coating Product Models, Descriptions and Specifications

12.7.4 Ideal Cures Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Ideal Cures Recent Developments

12.8 EasyCoat

12.8.1 EasyCoat Corporation Information

12.8.2 EasyCoat Business Overview

12.8.3 EasyCoat Pharmaceutical Coating Product Models, Descriptions and Specifications

12.8.4 EasyCoat Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 EasyCoat Recent Developments

12.9 Neha Life Sciences Pvt. Ltd.

12.9.1 Neha Life Sciences Pvt. Ltd. Corporation Information

12.9.2 Neha Life Sciences Pvt. Ltd. Business Overview

12.9.3 Neha Life Sciences Pvt. Ltd. Pharmaceutical Coating Product Models, Descriptions and Specifications

12.9.4 Neha Life Sciences Pvt. Ltd. Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Neha Life Sciences Pvt. Ltd. Recent Developments

12.10 Spraycel Coatings

12.10.1 Spraycel Coatings Corporation Information

12.10.2 Spraycel Coatings Business Overview

12.10.3 Spraycel Coatings Pharmaceutical Coating Product Models, Descriptions and Specifications

12.10.4 Spraycel Coatings Pharmaceutical Coating Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Spraycel Coatings Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Pharmaceutical Coating Industry Chain

13.2 Pharmaceutical Coating Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Pharmaceutical Coating Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Pharmaceutical Coating Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Pharmaceutical Coating Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Pharmaceutical Coating Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Pharmaceutical Coating Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Pharmaceutical Coating Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Pharmaceutical Coating Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Pharmaceutical Coating Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Pharmaceutical Coating Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Pharmaceutical Coating Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)

Table 7. Global Pharmaceutical Coating Sales by Region (2020-2025) & (Kilotons)

Table 8. Global Pharmaceutical Coating Sales by Region (2026-2031) & (Kilotons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Pharmaceutical Coating Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)

Table 11. Global Pharmaceutical Coating Production by Region (2020-2025) & (Kilotons)

Table 12. Global Pharmaceutical Coating Production by Region (2026-2031) & (Kilotons)

Table 13. Global Pharmaceutical Coating Sales by Manufacturers (2020-2025) & (Kilotons)

Table 14. Global Pharmaceutical Coating Sales Share by Manufacturers (2020-2025)

Table 15. Global Pharmaceutical Coating Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Pharmaceutical Coating Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Pharmaceutical Coating by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Coating as of 2024)

Table 19. Global Pharmaceutical Coating Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Pharmaceutical Coating Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers Pharmaceutical Coating Manufacturing Base and Headquarters

Table 22. Global Pharmaceutical Coating Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Pharmaceutical Coating Sales by Type (2020-2025) & (Kilotons)

Table 26. Global Pharmaceutical Coating Sales by Type (2026-2031) & (Kilotons)

Table 27. Global Pharmaceutical Coating Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Pharmaceutical Coating Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Pharmaceutical Coating ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Pharmaceutical Coating Sales by Application (2020-2025) & (Kilotons)

Table 32. Global Pharmaceutical Coating Sales by Application (2026-2031) & (Kilotons)

Table 33. Pharmaceutical Coating High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Pharmaceutical Coating Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Pharmaceutical Coating Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Pharmaceutical Coating ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Pharmaceutical Coating Growth Accelerators and Market Barriers

Table 40. North America Pharmaceutical Coating Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Pharmaceutical Coating Sales (Kilotons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Pharmaceutical Coating Growth Accelerators and Market Barriers

Table 43. Europe Pharmaceutical Coating Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Pharmaceutical Coating Sales (Kilotons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Pharmaceutical Coating Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Pharmaceutical Coating Sales (Kilotons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Pharmaceutical Coating Growth Accelerators and Market Barriers

Table 48. Southeast Asia Pharmaceutical Coating Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Pharmaceutical Coating Investment Opportunities and Key Challenges

Table 50. Central and South America Pharmaceutical Coating Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Pharmaceutical Coating Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Pharmaceutical Coating Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. BASF Corporation Information

Table 54. BASF Description and Major Businesses

Table 55. BASF Product Models, Descriptions and Specifications

Table 56. BASF Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. BASF Sales Value Proportion by Product in 2024

Table 58. BASF Sales Value Proportion by Application in 2024

Table 59. BASF Sales Value Proportion by Geographic Area in 2024

Table 60. BASF Pharmaceutical Coating SWOT Analysis

Table 61. BASF Recent Developments

Table 62. Evonik Corporation Information

Table 63. Evonik Description and Major Businesses

Table 64. Evonik Product Models, Descriptions and Specifications

Table 65. Evonik Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. Evonik Sales Value Proportion by Product in 2024

Table 67. Evonik Sales Value Proportion by Application in 2024

Table 68. Evonik Sales Value Proportion by Geographic Area in 2024

Table 69. Evonik Pharmaceutical Coating SWOT Analysis

Table 70. Evonik Recent Developments

Table 71. Kerry Corporation Information

Table 72. Kerry Description and Major Businesses

Table 73. Kerry Product Models, Descriptions and Specifications

Table 74. Kerry Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Kerry Sales Value Proportion by Product in 2024

Table 76. Kerry Sales Value Proportion by Application in 2024

Table 77. Kerry Sales Value Proportion by Geographic Area in 2024

Table 78. Kerry Pharmaceutical Coating SWOT Analysis

Table 79. Kerry Recent Developments

Table 80. UPM Pharmaceuticals Corporation Information

Table 81. UPM Pharmaceuticals Description and Major Businesses

Table 82. UPM Pharmaceuticals Product Models, Descriptions and Specifications

Table 83. UPM Pharmaceuticals Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. UPM Pharmaceuticals Sales Value Proportion by Product in 2024

Table 85. UPM Pharmaceuticals Sales Value Proportion by Application in 2024

Table 86. UPM Pharmaceuticals Sales Value Proportion by Geographic Area in 2024

Table 87. UPM Pharmaceuticals Pharmaceutical Coating SWOT Analysis

Table 88. UPM Pharmaceuticals Recent Developments

Table 89. Colorcon Corporation Information

Table 90. Colorcon Description and Major Businesses

Table 91. Colorcon Product Models, Descriptions and Specifications

Table 92. Colorcon Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Colorcon Sales Value Proportion by Product in 2024

Table 94. Colorcon Sales Value Proportion by Application in 2024

Table 95. Colorcon Sales Value Proportion by Geographic Area in 2024

Table 96. Colorcon Pharmaceutical Coating SWOT Analysis

Table 97. Colorcon Recent Developments

Table 98. Pharma Excipients Corporation Information

Table 99. Pharma Excipients Description and Major Businesses

Table 100. Pharma Excipients Product Models, Descriptions and Specifications

Table 101. Pharma Excipients Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. Pharma Excipients Recent Developments

Table 103. Ideal Cures Corporation Information

Table 104. Ideal Cures Description and Major Businesses

Table 105. Ideal Cures Product Models, Descriptions and Specifications

Table 106. Ideal Cures Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 107. Ideal Cures Recent Developments

Table 108. EasyCoat Corporation Information

Table 109. EasyCoat Description and Major Businesses

Table 110. EasyCoat Product Models, Descriptions and Specifications

Table 111. EasyCoat Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 112. EasyCoat Recent Developments

Table 113. Neha Life Sciences Pvt. Ltd. Corporation Information

Table 114. Neha Life Sciences Pvt. Ltd. Description and Major Businesses

Table 115. Neha Life Sciences Pvt. Ltd. Product Models, Descriptions and Specifications

Table 116. Neha Life Sciences Pvt. Ltd. Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 117. Neha Life Sciences Pvt. Ltd. Recent Developments

Table 118. Spraycel Coatings Corporation Information

Table 119. Spraycel Coatings Description and Major Businesses

Table 120. Spraycel Coatings Product Models, Descriptions and Specifications

Table 121. Spraycel Coatings Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 122. Spraycel Coatings Recent Developments

Table 123. Key Raw Materials Distribution

Table 124. Raw Materials Key Suppliers

Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 126. Milestones in Production Technology Evolution

Table 127. Distributors List

Table 128. Market Trends and Market Evolution

Table 129. Market Drivers and Opportunities

Table 130. Market Challenges, Risks, and Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceutical Coating Product Picture

Figure 2. Global Pharmaceutical Coating Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Tablets Product Picture

Figure 4. Pills Product Picture

Figure 5. Others Product Picture

Figure 6. Global Pharmaceutical Coating Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Medicines

Figure 8. Health Products

Figure 9. Others

Figure 10. Pharmaceutical Coating Report Years Considered

Figure 11. Global Pharmaceutical Coating Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 13. Global Pharmaceutical Coating Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Pharmaceutical Coating Revenue Market Share by Region (2020-2031)

Figure 15. Global Pharmaceutical Coating Sales (2020-2031) & (Kilotons)

Figure 16. Global Pharmaceutical Coating Sales (CAGR) by Region (2020-2031) (Kilotons)

Figure 17. Global Pharmaceutical Coating Sales Market Share by Region (2020-2031)

Figure 18. Global Pharmaceutical Coating Capacity, Production and Utilization (2020-2031) & (Kilotons)

Figure 19. Global Pharmaceutical Coating Production Trend by Region (2020-2031) (Kilotons)

Figure 20. Global Pharmaceutical Coating Production Market Share by Region (2020-2031)

Figure 21. Production Capacity Enablers & Constraints

Figure 22. Pharmaceutical Coating Production Growth Rate in North America (2020-2031) & (Kilotons)

Figure 23. Pharmaceutical Coating Production Growth Rate in Europe (2020-2031) & (Kilotons)

Figure 24. Pharmaceutical Coating Production Growth Rate in China (2020-2031) & (Kilotons)

Figure 25. Pharmaceutical Coating Production Growth Rate in Japan (2020-2031) & (Kilotons)

Figure 26. Top 5 and Top 10 Manufacturers Pharmaceutical Coating Sales Volume Market Share in 2024

Figure 27. Global Pharmaceutical Coating Revenue Market Share Ranking (2024)

Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 29. Tablets Revenue Market Share by Manufacturer in 2024

Figure 30. Pills Revenue Market Share by Manufacturer in 2024

Figure 31. Others Revenue Market Share by Manufacturer in 2024

Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 34. Global Pharmaceutical Coating Sales Market Share by Type (2020-2031)

Figure 35. Global Pharmaceutical Coating Revenue Market Share by Type (2020-2031)

Figure 36. Global Pharmaceutical Coating Sales Market Share by Application (2020-2031)

Figure 37. Global Pharmaceutical Coating Revenue Market Share by Application (2020-2031)

Figure 38. North America Pharmaceutical Coating Sales YoY (2020-2031) & (Kilotons)

Figure 39. North America Pharmaceutical Coating Revenue YoY (2020-2031) & (US$ Million)

Figure 40. North America Top 5 Manufacturers Pharmaceutical Coating Sales Revenue (US$ Million) in 2024

Figure 41. North America Pharmaceutical Coating Sales Volume (Kilotons) by Type (2020- 2031)

Figure 42. North America Pharmaceutical Coating Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 43. North America Pharmaceutical Coating Sales Volume (Kilotons) by Application (2020-2031)

Figure 44. North America Pharmaceutical Coating Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. US Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 47. Mexico Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 48. Europe Pharmaceutical Coating Sales YoY (2020-2031) & (Kilotons)

Figure 49. Europe Pharmaceutical Coating Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Europe Top 5 Manufacturers Pharmaceutical Coating Sales Revenue (US$ Million) in 2024

Figure 51. Europe Pharmaceutical Coating Sales Volume (Kilotons) by Type (2020-2031)

Figure 52. Europe Pharmaceutical Coating Sales Revenue (US$ Million) by Type (2020-2031)

Figure 53. Europe Pharmaceutical Coating Sales Volume (Kilotons) by Application (2020-2031)

Figure 54. Europe Pharmaceutical Coating Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Germany Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 56. France Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 57. U.K. Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 58. Italy Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 59. Russia Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Pharmaceutical Coating Sales YoY (2020-2031) & (Kilotons)

Figure 61. Asia-Pacific Pharmaceutical Coating Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Asia-Pacific Top 8 Manufacturers Pharmaceutical Coating Sales Revenue (US$ Million) in 2024

Figure 63. Asia-Pacific Pharmaceutical Coating Sales Volume (Kilotons) by Type (2020- 2031)

Figure 64. Asia-Pacific Pharmaceutical Coating Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 65. Asia-Pacific Pharmaceutical Coating Sales Volume (Kilotons) by Application (2020-2031)

Figure 66. Asia-Pacific Pharmaceutical Coating Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Indonesia Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 68. Japan Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 71. India Pharmaceutical Coating Revenue (2020-2031) & (US$ Million)

Figure 72. Central and South America Pharmaceutical Coating Sales YoY (2020-2031) & (Kilotons)

Figure 73. Central and South America Pharmaceutical Coating Revenue YoY (2020-2031) & (US$ Million)

Figure 74. Central and South America Top 5 Manufacturers Pharmaceutical Coating Sales Revenue (US$ Million) in 2024

Figure 75. Central and South America Pharmaceutical Coating Sales Volume (Kilotons) by Type (2021-2031)

Figure 76. Central and South America Pharmaceutical Coating Sales Revenue (US$ Million) by Type (2020-2031)

Figure 77. Central and South America Pharmaceutical Coating Sales Volume (Kilotons) by Application (2020-2031)

Figure 78. Central and South America Pharmaceutical Coating Sales Revenue (US$ Million) by Application (2020-2031)

Figure 79. Brazil Pharmaceutical Coating Revenue (2020-2025) & (US$ Million)

Figure 80. Argentina Pharmaceutical Coating Revenue (2020-2025) & (US$ Million)

Figure 81. Middle East, and Africa Pharmaceutical Coating Sales YoY (2020-2031) & (Kilotons)

Figure 82. Middle East and Africa Pharmaceutical Coating Revenue YoY (2020-2031) & (US$ Million)

Figure 83. Middle East and Africa Top 5 Manufacturers Pharmaceutical Coating Sales Revenue (US$ Million) in 2024

Figure 84. Middle East and Africa Pharmaceutical Coating Sales Volume (Kilotons) by Type (2021-2031)

Figure 85. South America Pharmaceutical Coating Sales Revenue (US$ Million) by Type (2020-2031)

Figure 86. Middle East and Africa Pharmaceutical Coating Sales Volume (Kilotons) by Application (2020-2031)

Figure 87. Middle East and Africa Pharmaceutical Coating Sales Revenue (US$ Million) by Application (2020-2031)

Figure 88. GCC Countries Pharmaceutical Coating Revenue (2020-2025) & (US$ Million)

Figure 89. Turkey Pharmaceutical Coating Revenue (2020-2025) & (US$ Million)

Figure 90. Egypt Pharmaceutical Coating Revenue (2020-2025) & (US$ Million)

Figure 91. South Africa Pharmaceutical Coating Revenue (2020-2025) & (US$ Million)

Figure 92. Pharmaceutical Coating Industry Chain Mapping

Figure 93. Regional Pharmaceutical Coating Manufacturing Base Distribution (%)

Figure 94. Pharmaceutical Coating Production Process

Figure 95. Regional Pharmaceutical Coating Production Cost Structure

Figure 96. Channels of Distribution (Direct Vs Distribution)

Figure 97. Bottom-up and Top-down Approaches for This Report

Figure 98. Data Triangulation

Figure 99. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmaceutical Coating market? zhanKai

The top companies in the global Pharmaceutical Coating market are BASF、Evonik、Kerry.

Related Reports

Global Pharmaceutical Coating Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharmaceutical Coating market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 148
USD 4900.00
(Single User License)
Global Pharmaceutical Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Coating market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 80
USD 4250.00
(Single User License)
Pharmaceutical Coating- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Coating was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 106
USD 3950.00
(Single User License)
Global Pharmaceutical Coating Market Research Report 2026
The global Pharmaceutical Coating market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 127
USD 2900.00
(Single User License)
Global Pharmaceutical Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Coating market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 79
USD 4250.00
(Single User License)
Global Pharmaceutical Coating Market Research Report 2025
The global market for Pharmaceutical Coating was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 93
USD 2900.00
(Single User License)
Pharmaceutical Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Coating was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 93
USD 3950.00
(Single User License)
Global and United States Pharmaceutical Coating Market Report & Forecast 2024-2030
Drug coating is the process of applying sugar or other film-forming materials to the outer surface of solid drug preparations (such as tablets, pills, etc.) in specific equipment according to a specific process, so that after drying, it becomes one or more multifunctional protective layers of different thicknesses and elasticities that are tightly adhered to the surface.
Published Date: 2024-07-17
Pages: 107
USD 4350.00
(Single User License)
Global Pharmaceutical Coating Market Research Report 2024
Drug coating is the process of applying sugar or other film-forming materials to the outer surface of solid drug preparations (such as tablets, pills, etc.) in specific equipment according to a specific process, so that after drying, it becomes one or more multifunctional protective layers of different thicknesses and elasticities that are tightly adhered to the surface.
Published Date: 2024-07-17
Pages: 89
USD 2900.00
(Single User License)
Global Pharmaceutical Coating Market Insights, Forecast to 2030
Drug coating is the process of applying sugar or other film-forming materials to the outer surface of solid drug preparations (such as tablets, pills, etc.) in specific equipment according to a specific process, so that after drying, it becomes one or more multifunctional protective layers of different thicknesses and elasticities that are tightly adhered to the surface.
Published Date: 2024-07-17
Pages: 148
USD 4900.00
(Single User License)

Global Pharmaceutical Coating Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharmaceutical Coating market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 148
USD 4900.00 (Single User License)
Global Pharmaceutical Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Coating market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 80
USD 4250.00 (Single User License)
Pharmaceutical Coating- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Coating was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 106
USD 3950.00 (Single User License)
Global Pharmaceutical Coating Market Research Report 2026
The global Pharmaceutical Coating market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 127
USD 2900.00 (Single User License)
Global Pharmaceutical Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Coating market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 79
USD 4250.00 (Single User License)
Global Pharmaceutical Coating Market Research Report 2025
The global market for Pharmaceutical Coating was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 93
USD 2900.00 (Single User License)
Pharmaceutical Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Coating was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 93
USD 3950.00 (Single User License)
Global and United States Pharmaceutical Coating Market Report & Forecast 2024-2030
Drug coating is the process of applying sugar or other film-forming materials to the outer surface of solid drug preparations (such as tablets, pills, etc.) in specific equipment according to a specific process, so that after drying, it becomes one or more multifunctional protective layers of different thicknesses and elasticities that are tightly adhered to the surface.
Published: 2024-07-17
Pages: 107
USD 4350.00 (Single User License)
Global Pharmaceutical Coating Market Research Report 2024
Drug coating is the process of applying sugar or other film-forming materials to the outer surface of solid drug preparations (such as tablets, pills, etc.) in specific equipment according to a specific process, so that after drying, it becomes one or more multifunctional protective layers of different thicknesses and elasticities that are tightly adhered to the surface.
Published: 2024-07-17
Pages: 89
USD 2900.00 (Single User License)
Global Pharmaceutical Coating Market Insights, Forecast to 2030
Drug coating is the process of applying sugar or other film-forming materials to the outer surface of solid drug preparations (such as tablets, pills, etc.) in specific equipment according to a specific process, so that after drying, it becomes one or more multifunctional protective layers of different thicknesses and elasticities that are tightly adhered to the surface.
Published: 2024-07-17
Pages: 148
USD 4900.00 (Single User License)